Building a diverse biomedical sciences workforce is a critical step in reducing the burden of cancer for an increasingly diverse America.

Funders Concerned About AIDS (FCAA) issues a call for data.

An HIV advocate shares his thoughts about an essay by activist, author and blogger Mark S. King.

Experts respond to CDC’s recently published HIV Surveillance Supplemental Report.

Ideally, all patients with advanced cancers would be in clinical trials. Until then, the right to try is an option we all should have.

Right to Try bills attack the one agency tasked with verifying the safety and efficacy of medications.

An open letter by more than 200 HIV scientists, researchers and clinicians denouncing the deterioration of U.S. evidence-based policymaking.

The chair of HIV Medicine Association (HIVMA) responds to Trump’s budget proposal.

The yearlong effort, “#StigmaStops,” launches on Zero Discrimination Day, March 1. Here’s how you can get involved.